Tech Company Financing Transactions
Locana Funding Round
Arch Venture Partners, GV and Lightstone Ventures participated in a $55 million Series A funding round for Locana. This venture round was announced on 5/23/2019.
Transaction Overview
Company Name
Announced On
5/23/2019
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds will be used to advance and expand Locana's pipeline of RNA-targeting gene therapy programs, further extend capabilities of the Locana platform technology, and assemble a premier leadership team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3545 John Hopkins Ct. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Differences in our DNA have consequences ranging from inability to enjoy cilantro to devastating genetic disease. But one thing is the same among many of these mutated DNA sequences -- targeting the RNA produced by them is a powerful way to treat them. One reason to address DNA mutations through the RNA they produce is to eliminate off-target effects (potentially harmful changes) in DNA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Burns
Chief Scientific Officer
Kathie Bishop
Controller
Carolyn Bonebright
VP - Bus. Development
Micah Mackison
VP - Bus. Development
Samantha Murphy
VP - Human Resources
Holly Winter
VP - R & D
Ronald Batra
Browse more venture capital transactions:
Prev: 5/23/2019: Wild Earth venture capital transaction
Next: 5/23/2019: Concentric Analgesics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs